CLDXCelldex Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Celldex Therapeutics, Inc. against SIC 2835 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CLDXThis | $2.3B#4 | — | 3.3x#9 | 1510.6x#14 | -78.0%#14 | -63.9%#14 | -18599.8%#12 | -36.2%#5 | — | — | 20.1%#4 | — |
| IDXX | $53.0B#1 | 45.3x#3 | 28.3x#12 | 12.3x#10 | 10.4%#4 | 19.3%#9 | 31.6%#1 | 56.7%#1 | 53.2%#1 | 9#1 | -7.0%#5 | — |
| LNTH | $6.6B#2 | 24.1x#2 | 5.0x#10 | 4.3x#8 | 0.5%#6 | -25.2%#12 | 20.2%#2 | 17.8%#2 | 18.1%#2 | 4#4 | — | 0.0%#1 |
| NEOG | $2.6B#3 | — | 1.3x#5 | 3.0x#7 | -2.7%#9 | 99.3%#1 | -2.5%#3 | -0.4%#3 | -0.8%#3 | 5#2 | 92.2%#1 | — |
| NTLA | $1.7B#5 | — | 2.3x#8 | 24.6x#12 | 16.9%#3 | 20.5%#8 | -651.7%#9 | -56.7%#6 | — | — | -9.3%#6 | — |
| QDEL | $969M#6 | — | 0.5x#3 | 0.4x#1 | -1.9%#8 | 44.8%#3 | -33.7%#4 | -63.2%#7 | -19.4%#4 | — | — | — |
| ACHV | $695M#7 | — | — | — | — | -37.2%#13 | — | — | — | — | 32.2%#3 | — |
| MYGN | $578M#8 | — | 1.9x#6 | 0.7x#2 | -1.6%#7 | -188.2%#15 | -47.0%#6 | -120.4%#12 | -76.1%#7 | — | — | — |
| TKNO | $394M#9 | — | 6.3x#11 | 9.7x#9 | 7.4%#5 | 35.5%#4 | -41.9%#5 | -27.6%#4 | -25.2%#5 | 5#2 | 44.4%#2 | — |
| ICCC | $96M#10 | — | — | — | — | — | — | — | — | — | — | — |
| IMDX | $90M#11 | — | — | 22.1x#11 | 115.6%#1 | 17.2%#10 | -1260.8%#11 | — | — | — | — | — |
| BMRA | $8M#12 | — | 2.2x#7 | 1.8x#4 | -16.2%#11 | 24.1%#5 | -119.5%#7 | -103.5%#11 | — | — | — | — |
| CDIO | $5M#13 | — | 0.6x#4 | 321.4x#13 | -57.5%#12 | 22.5%#6 | -43737.5%#13 | -87.5%#9 | — | — | — | — |
| QCLS | $3M#14 | 0.0x#1 | 0.2x#2 | 2.2x#5 | -5.3%#10 | 50.2%#2 | -624.4%#8 | -72.3%#8 | -61.2%#6 | — | — | — |
| VNRX | $3M#15 | — | — | 1.5x#3 | 40.0%#2 | 13.4%#11 | -1258.5%#10 | — | — | — | — | — |
| CDIOW | $40249#16 | — | 0.0x#1 | 2.7x#6 | -57.5%#12 | 22.5%#6 | -43737.5%#13 | -87.5%#9 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2835). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice